期刊文献+

脓毒症与相关生物分子关系的研究 被引量:1

Study on the Relationship Between Sepsis and Related Biomolecules
下载PDF
导出
摘要 脓毒症是由感染引起的全身炎症反应综合征,身体任何部分感染都有可能引发此病,其发病率、死亡率极高。据统计,目前全球每年约有超过1900万脓毒症患者,大部分由严重感染引起,已成为威胁人类生命健康和安全的重大疾病之一。目前,关于脓毒症发生发展的机制研究已进入分子水平,本文主要就相关生物分子在脓毒症的诊断、治疗及预后评估等方面的作用进行综述,以期为临床治疗脓毒症提供指导方向。 Sepsis is a systemic inflammatory response syndrome caused by infection.Infection of any part of the body may cause this disease,and its morbidity and mortality are extremely high.According to statistics,there are currently more than 19 million sepsis patients in the world each year,most of which are caused by serious infections,and have become one of the major diseases that threaten human life,health and safety.At present,research on the mechanism of the occurrence and development of sepsis has entered the molecular level.This article mainly reviews the role of related biomolecules in the diagnosis,treatment and prognosis evaluation of sepsis,in order to provide guidance for the clinical treatment of sepsis.
作者 陆政 LU Zheng(Second Ward,Department of Critical Care Medicine,the People's Hospital of Guangxi Zhuang Autonomous Region,Nanning 530021,Guangxi,China)
出处 《医学信息》 2021年第14期51-53,共3页 Journal of Medical Information
关键词 脓毒症 全身炎症反应综合征 血浆游离DNA 长链非编码RNA Sepsis Systemic inflammatory response syndrome Plasma free DNA Long non-coding RNA
  • 相关文献

参考文献19

二级参考文献136

  • 1郭磊,沈华,张铮.脓毒症的新型生物标志物研究进展[J].内科急危重症杂志,2020(2):155-158. 被引量:13
  • 2徐作军,丁可,黄慧,孙铁英,柯会星,童朝辉,危天倪,彭堃,姚彬,李凤仙,刘建华.社区获得性肺炎诊断和治疗指南临床应用调查及490例病例分析[J].中华结核和呼吸杂志,2007,30(6):442-446. 被引量:34
  • 3MARSHALL JC,REINHART K,InternationalSepsis Forum. Biomarkers of sepsis[J]. Crit CareMed,2009,37(7):2290-2298.
  • 4SIMON L,GAUVIN F,AMRE DK,et al. Serumprocalcitonin and C-reactive protein levels as markersof bacterial infection:a systematic review and metaanalysis[J]. Clin Infect Dis,2004,39(2):206-217.
  • 5BOUADMA L,LUYT CE,TUBACH F,et al.Use of procalcitonin to reduce patients' exposureto antibiotics in intensive care units (PRORATAtrial):a multicentre randomised controlled trial[J].Lancet,2010,375(9713):463-474.
  • 6TANG BM,ESLICK GD,GRAIG JC,et al. Accuracyof procalcitonin for sepsis diagnosis in critically illpatients:systematic review and meta-analysis[J]. LancetInfect Dis,2007,7(3):210-217.
  • 7CHRIST-GRAIN M, MU LLER B. Procalcitonin inbacterial infections-hype,hope,more or less-[J].Swiss Med Wkly,2005,135(5):451-460.
  • 8RAMIREZ P,GARCIA MA,FERRER M,et al.Sequential measurements of procalcitonin levels indiagnosing ventilator-associated pneumonia[J]. EurRespir J,2008,31(2):356-362.
  • 9MEHANIC S,BALJIC R. The importance of serumprocalcitonin in diagnosis and treatment of seriousbacterial infections and sepsis [J]. Mater Sociomed,2013,25(4):277-281.
  • 10Hotchkiss RS,Monneret G,Payen D. Sepsis-induced immunosup-pression :from cellular dysfunctions to immunotherapy [ J ] . NatRev Immunol,2013,13( 12) :862 -874.

共引文献242

同被引文献24

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部